Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2011 1
2012 1
2013 3
2014 1
2015 4
2016 1
2018 1
2019 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia Diagnostics.
Alonso CM, Llop M, Sargas C, Pedrola L, Panadero J, Hervás D, Cervera J, Such E, Ibáñez M, Ayala R, Martínez-López J, Onecha E, de Juan I, Palanca S, Martínez-Cuadrón D, Rodríguez-Veiga R, Boluda B, Montesinos P, Sanz G, Sanz MA, Barragán E. Alonso CM, et al. Among authors: de juan i. J Mol Diagn. 2019 Mar;21(2):228-240. doi: 10.1016/j.jmoldx.2018.09.009. Epub 2018 Dec 19. J Mol Diagn. 2019. PMID: 30576870 Free article.
Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients.
Fuster O, Llop M, Dolz S, García P, Such E, Ibáñez M, Luna I, Gómez I, López M, Cervera J, Montesinos P, Moscardó F, Cordón L, Solves P, de Juan I, Palanca S, Bolufer P, Sanz MÁ, Barragán E. Fuster O, et al. Among authors: de juan i. Leuk Res. 2013 Dec;37(12):1690-6. doi: 10.1016/j.leukres.2013.09.015. Epub 2013 Sep 21. Leuk Res. 2013. PMID: 24199710
Implementation of massive sequencing in the genetic diagnosis of hereditary cancer syndromes: diagnostic performance in the Hereditary Cancer Programme of the Valencia Community (FamCan-NGS).
Ramírez-Calvo M, García-Casado Z, Fernández-Serra A, de Juan I, Palanca S, Oltra S, Soto JL, Castillejo A, Barbera VM, Juan-Fita MJ, Segura Á, Chirivella I, Sánchez AB, Tena I, Chaparro C, Salas D, López-Guerrero JA. Ramírez-Calvo M, et al. Among authors: de juan i. Hered Cancer Clin Pract. 2019 Jan 18;17:3. doi: 10.1186/s13053-019-0104-x. eCollection 2019. Hered Cancer Clin Pract. 2019. PMID: 30675318 Free PMC article.
Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital.
Simarro J, Murria R, Pérez-Simó G, Llop M, Mancheño N, Ramos D, Juan I, Barragán E, Laiz B, Cases E, Ansótegui E, Gómez-Codina J, Aparicio J, Salvador C, Juan Ó, Palanca S. Simarro J, et al. Among authors: juan i. Cancers (Basel). 2019 Aug 16;11(8):1196. doi: 10.3390/cancers11081196. Cancers (Basel). 2019. PMID: 31426418 Free PMC article.
Fragment length analysis screening for detection of CEBPA mutations in intermediate-risk karyotype acute myeloid leukemia.
Fuster O, Barragán E, Bolufer P, Such E, Valencia A, Ibáñez M, Dolz S, de Juan I, Jiménez A, Gómez MT, Buño I, Martínez J, Cervera J, Montesinos P, Moscardó F, Sanz MÁ. Fuster O, et al. Among authors: de juan i. Ann Hematol. 2012 Jan;91(1):1-7. doi: 10.1007/s00277-011-1234-z. Epub 2011 May 3. Ann Hematol. 2012. PMID: 21538063
Novel real-time polymerase chain reaction assay for simultaneous detection of recurrent fusion genes in acute myeloid leukemia.
Dolz S, Barragán E, Fuster Ó, Llop M, Cervera J, Such E, De Juan I, Palanca S, Murria R, Bolufer P, Luna I, Gómez I, López M, Ibáñez M, Sanz MA. Dolz S, et al. Among authors: de juan i. J Mol Diagn. 2013 Sep;15(5):678-86. doi: 10.1016/j.jmoldx.2013.04.003. Epub 2013 Jun 25. J Mol Diagn. 2013. PMID: 23806810 Free article.
13 results